Antimicrobial resistance trends in blood culture positive Salmonella Paratyphi A isolates from Pondicherry, India

被引:7
作者
Menezes, G. A. [1 ,2 ]
Harish, B. N. [2 ]
Khan, M. A. [1 ,3 ]
Goessens, W. [3 ]
Hays, J. P. [3 ]
机构
[1] Hail Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Mol Diagnost & Personalised Therapeut Unit, Hail, Saudi Arabia
[2] Jawaharlal Inst Postgrad Med Educ & Res, Dept Microbiol, Inst Natl Importance, Pondicherry, India
[3] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands
关键词
Blood culture; ciprofloxacin; gyrA; multi-drug resistant; Salmonella Paratyphi A; ENTERICA SEROTYPE PARATYPHI; MAJOR CAUSE; FEVER; EMERGENCE; ASIA;
D O I
10.4103/0255-0857.180352
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Enteric fever is a public health problem with the upsurge in the occurrence of Salmonella isolates that are resistant to ciprofloxacin. In this study, a total of 284 blood culture isolates of S. Paratyphi A were investigated. Of these isolates, 281 (98.9%) were nalidixic acid resistant. A high rate (6.3%) of high-level resistance (>= 4 mu g/mL) was found to ciprofloxacin. The isolates with ciprofloxacin minimum inhibitory concentrations (MICs) of >= 12 mu g/mL had 4 mutations, 2 mutations within the quinolone resistance-determining region of gyrA and 2 mutations also in parC. According to the Clinical Laboratory Standards Institute 2012 MIC breakpoints, 75.0% of isolates were resistant to ciprofloxacin. Finally, 3 major pulsed-field gel electrophoresis patterns were observed among the S. Paratyphi A isolates. The spread of fluoroquinolone resistant S. Paratyphi A necessitates a change toward 'evidence-based' treatment for enteric fever. The research provides a perspective on the increasing prevalence of antimicrobial resistant S. Paratyphi A isolates in this region of India.
引用
收藏
页码:222 / 227
页数:6
相关论文
共 18 条
  • [1] Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India
    Brown, JC
    Shanahan, PMA
    Jesudason, MV
    Thomson, CJ
    Amyes, SGB
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 891 - 900
  • [2] Drug-resistant Salmonella enterica serotype Paratyphi A in India
    Chandel, DS
    Chaudhry, R
    Dhawan, B
    Pandey, A
    Dey, AB
    [J]. EMERGING INFECTIOUS DISEASES, 2000, 6 (04) : 420 - 421
  • [3] Clinical and Laboratory Standards Institute (CLSI), 2011, M100S21 CLSI, V31
  • [4] [CLSI]. Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI, V32, pM100
  • [5] European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, CLIN BREAKP DOC VERS
  • [6] Emergence of Salmonella paratyphi A as a major cause of enteric fever:: Need for early detection, preventive measures, and effective vaccines
    Fangtham, Monthida
    Wilde, Henry
    [J]. JOURNAL OF TRAVEL MEDICINE, 2008, 15 (05) : 344 - 350
  • [7] Genetic diversity of Salmonella enterica serovar Paratyphi A from different geographical regions in Asia
    Goh, YL
    Puthucheary, SD
    Chaudhry, R
    Bhutta, ZA
    Lesmana, M
    Oyofo, BA
    Punjabi, NH
    Ahmed, A
    Thong, KL
    [J]. JOURNAL OF APPLIED MICROBIOLOGY, 2002, 92 (06) : 1167 - 1171
  • [8] Harish BN, 2006, INDIAN J MED RES, V124, P585
  • [9] Antimicrobial resistance in typhoidal salmonellae
    Harish, B. N.
    Menezes, G. A.
    [J]. INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 29 (03) : 223 - 229
  • [10] Harish B. N., 2011, WHO S E ASIA REGION, V15, P92